Skip to content
Medical Health Aged Care

Avania Strengthens Leadership Team With Pivotal Executive Appointments

Avania 2 mins read
BILTHOVEN, Netherlands & BOSTON--BUSINESS WIRE--

Avania — the leading global MedTech advisory and clinical development partner — today announced the appointments of Jasmine Saba as sr. vice president of strategic relationships and Josh Blacker as sr. vice president of global business development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250417247152/en/

Jasmine Saba (left) has been appointed Sr. Vice President of Strategic Relationships. Josh Blacker (right) joins Avania as Sr. Vice President of Global Business Development.

Jasmine Saba (left) has been appointed Sr. Vice President of Strategic Relationships. Josh Blacker (right) joins Avania as Sr. Vice President of Global Business Development.

Saba Appointed Sr. Vice President of Strategic Relationships

Saba will take on this new role to support Avania’s growth by identifying, building, and nurturing key partnerships with global multinational medical technology companies. She will develop repeatable and scalable solutions leveraging Avania’s partnership approach as these customers increasingly rely on Avania to be an extension of their existing teams. With her extensive experience in R&D, clinical operations, and sales, Saba has a proven track record in building long-term strategic partnerships and helping them pivot based on pressing market demands.

Blacker Joins as Sr. Vice President of Global Business Development

Blacker will be responsible for leading Avania’s global business development team across all three regions including NA, EU, and APAC with a focus on MedTech companies at all stages of their development. Blacker brings a wealth of experience building robust business development programs at Chiltern, Worldwide Clinical Trials, and Evestia Clinical, where he was most recently executive vice president of commercial. With deep industry expertise Blacker is well-positioned to support Avania’s strategic goals.

“We recognize the MedTech industry is consistently changing and remain committed to providing flexible solution-driven partnerships that guide our clients from concept to commercialization. Our ability to navigate the changes in the industry is rooted in the strength of our team,” said Jason Monteleone, president and CEO of Avania. “I’m thrilled to welcome Josh Blacker, and I’m equally excited to announce Jasmine Saba into her new role. Both are strategic moves that further enhance our ability to meet client needs.”

About Avania

Avania is the leading global MedTech advisory and clinical development partner with a focus on medical devices, diagnostics/IVDs, and digital health. Core offerings include full service clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being. When you need to advance your medical technology, It Takes Avania.


Contact details:

Gabe Martinez
SCORR Marketing
+1 (308) 338 2304
[email protected]

Media

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 14/02/2026
  • 06:00
Leukaemia Foundation

International Childhood Cancer Day highlights blood cancer as the biggest cancer threat to Australian children

Blood cancer is the most commonly diagnosed childhood cancer in Australia[i] – and its growing impact is robbing far too many young Australians of…

  • Contains:
  • Medical Health Aged Care
  • 13/02/2026
  • 13:36
Royal Australian College of GPs

RACGP calls on SA Government to ensure evidence-based approach to primary care reforms

The Royal Australian College of GPs (RACGP) has called on the SA Government to match the position laid out by Liberal health spokesperson Heidi Girolamo on the role of pharmacists and GPs in primary care, emphasising the importance of safe, coordinated and evidence-based models that support the best outcomes for South Australians. RACGP SA Chair Dr Sian Goodson said the SA Liberal’s position highlights the need for careful consideration of how different parts of the health system interact. “There is currently no serious evidence base supporting pharmacy prescribing trials, and that lack of rigorous data raises real concerns about patient…

  • Contains:
  • Medical Health Aged Care
  • 13/02/2026
  • 11:02
Royal Australian College of GPs

Convenience can’t come at the cost of safety: RACGP calls for safeguards on WA pharmacy pilot

The Royal Australian College GPs (RACGP) has called for guardrails to protect patient safety, following a WA Government announcement that a further 40 pharmacists will commence training this monthto diagnose and treat Western Australians for a range of conditions as part of the Enhanced Access Community Pharmacy Pilot. RACGP WA Chair Dr Ramya Raman said GPs support innovation, but any reforms must strike the right balance between improving access and ensuring quality patient care. “Patients deserve convenience and safety. We support innovation, but diagnosis, follow-up and continuity aren’t optional extras,” she said. “These safeguards exist for a reason, to catch…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.